{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles all mention \"Lockdown\" but the passages are either just \"Passage: Lockdown\" repeated or \"banned Implemented with lockdown.57 24/3/2020\". Hmm, that's a bit confusing. The context might be incomplete or there's some formatting issue here.\n\nFirst, I need to figure out what a lockdown is based on general knowledge. A lockdown is typically a strict public health measure where people are required to stay at home, non-essential businesses are closed, and movement is restricted to prevent the spread of a disease, like during a pandemic. The context mentions estimating infections and the impact of non-lockdown, which suggests that the study or report is comparing scenarios with and without lockdowns to assess their effectiveness in controlling the spread of the virus.\n\nBut the provided context doesn't have detailed information. The user might be expecting an answer based on the given context, but since the context is minimal, maybe they want a standard definition. However, since the context is about lockdowns in the context of infections, I should tie the answer to that. Also, the date mentioned is 24/3/2020, which is around when many countries started implementing lockdowns due to the COVID-19 pandemic. \n\nSo, putting it all together, a lockdown is a public health intervention to limit movement and gatherings to reduce the transmission of infectious diseases. The context's focus on estimating infections suggests that lockdowns are being analyzed for their effectiveness in reducing the number of cases. The answer should mention that lockdowns are measures to restrict movement and gatherings, implemented to control disease spread, as seen in the context of the 2020 pandemic.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of infectious diseases, such as during a pandemic. It typically involves closing non-essential businesses, schools, and public spaces, limiting travel, and enforcing stay-at-home orders. The context provided suggests that lockdowns were studied as part of efforts to estimate their impact on reducing infections, particularly in response to the 2020 pandemic (as indicated by the date 24/3/2020).",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know is Chikungunya virus. Let me look back at the provided context to make sure I get all the details right.\n\nFirst, the passage mentions that more than 50% of patients with severe CHIKF (Chikungunya Fever) are over 65 years old, and over a third die. But the question is about complications, not just demographics. The next part says most adults with severe CHIKF have underlying medical conditions. Then it lists the complications from most common to least: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. \n\nWait, there's also a part about neonates. The passage talks about mothers transmitting CHIKV to their babies during the perinatal period, leading to high morbidity. By day 4, all neonates were symptomatic, and six had meningoencephalitis. Another part mentions nineteen cases of neonatal infection leading to encephalitis due to vertical transmission. So neonatal complications include encephalitis and other symptoms similar to CHIKF.\n\nI need to list all the complications mentioned. The main ones in adults are the seven listed. For neonates, it's encephalitis and other symptoms. Also, the passage mentions \"other central nervous system problems,\" which might include the neonatal encephalitis. But I should make sure not to repeat. Let me check again.\n\nThe complications listed in order are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. Then specifically for neonates, encephalitis is mentioned again. Also, the neonates had common CHIKF symptoms, which might include fever, rash, etc., but the question is about complications, so maybe just the severe ones. The answer should include all the listed complications from the passage, both in adults and neonates. So compiling them all: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS issues, kidney failure, and neonatal encephalitis from vertical transmission. Also, the passage mentions \"other complications associated with CHIKV,\" so",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.7,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I don't see any mention of a clade labeled \"A\". The passages talk about clades like 1B.1, 1B.2, 1C, 1A.1, and 1A.1.1. There's also mention of clades in the 1C lineage and some exceptions for 1A.1 and 1A.1.1. \n\nWait, the first passage mentions \"the first-order 1A.1 and the extensive 1A.1.1 second-order clade\" as exceptions. So maybe there's a clade referred to as 1A.1? But the question is about Clade A. Maybe there's a typo or misunderstanding here. The user might have meant Clade 1A.1 or another clade. Alternatively, perhaps the answer is that Clade A isn't mentioned in the provided context. \n\nLooking again, the titles and passages don't mention any clade labeled \"A\" by itself. All clades are numbered with numbers and letters like 1B.1, 1C, etc. The term \"Other-Avian\" is mentioned, but that's not a clade labeled A. The answer might be that there's no information provided about Clade A in the given context. Alternatively, maybe the user confused the labeling system. Since the answer requires using the context, and there's no Clade A mentioned, the correct answer would be that the context does not provide information on Clade A.\n</think>\n\nThe provided context does not mention a clade specifically labeled \"Clade A.\" The passages discuss clades such as 1B.1, 1B.2, 1C, 1A.1, and 1A.1.1, but there is no reference to a clade designated as \"A\" in isolation. Therefore, based on the given information, **Clade A is not described in the context**.",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations .",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception."
      ],
      "computed_relevance": 0.5454545454545454,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S2 subunit is highly conserved with 99% identity between 2019-nCoV, bat SARS-like CoVs, and human SARS-CoV. But the question is about the S1 subunit.\n\nLooking further, the passage states: \"the S1 subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV.\" So the key point here is the 70% identity. Also, it mentions that the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the RBD is part of the S1 subunit, right? The S1 subunit is responsible for receptor binding, so the core domain's high conservation might be important for function. Also, the context notes that unlike 2019-nCoV and human SARS-CoV, most bat SARSr-CoVs have two deletions in the spike receptor binding domain compared to human SARS-CoV. But since the question is about S1 subunit comparison, the main numbers are the 70% identity and the conserved RBD core.\n\nSo putting it together: The S1 subunit of 2019-nCoV has about 70% identity with bat SARS-like CoVs and human SARS-CoV. The core domain of the RBD is highly conserved. The answer should mention both the 70% identity and the conserved RBD core. Also, note that bat SARS-related CoVs have deletions in the RBD, but that's more about the S1's RBD structure differences. But the question is about the comparison of the S1 subunits in terms of identity. So the answer should focus on the 70% identity and the conserved RBD core.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% identity** with the S1 subunits of bat SARS-like CoVs and human SARS-CoV. While the",
      "retrieved_chunks": [
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from a passage titled \"Secretome of Intestinal Bacilli: A Natural Guard against Pathologies.\" \n\nFirst, I need to parse through the given context to find relevant information about Bacillus subtilis. The passage mentions that Bacillus species, specifically B. subtilis, are found in traditional fermented foods and are used in probiotics. It also states that unlike Lactobacillus, Bacillus was not initially considered part of the normal intestinal microbiome but has been found in feces. \n\nThe passage explains that B. subtilis helps restore gut microflora by increasing beneficial bacteria like Bifidobacterium, Lactobacillus, and Butyricicoccus, while reducing harmful species like Acinetobacter, Ruminococcus, Clostridium, and Veillonella. Additionally, it mentions that B. subtilis produces surfactins, fengycins, and iturins in a specific ratio (6:37:57). \n\nI should also note that Bacillus species are present in environments like decomposing plants. The context emphasizes the role of B. subtilis in maintaining gut health through its secretome, which includes these antimicrobial compounds. \n\nPutting this together, the answer should define B. subtilis as a species of Bacillus used in probiotics, found in fermented foods, which helps balance gut microbiota by producing specific compounds. It's important to highlight its role in both the gut and environment, as well as its mechanisms of action.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus, historically found in traditional fermented foods and increasingly recognized for its probiotic properties. It is used in commercial probiotics (e.g., Biosubtyl, Biosporin) to support intestinal health by restoring gut microbiota balance. Specifically, **B. subtilis** promotes beneficial bacteria like *Bifidobacterium*, *Lactobacillus*, and *Butyricicoccus* while suppressing harmful species such as *Clostridium* and *Acinetobacter*. It produces antimicrobial compounds\u2014surfactins, fengycins, and iturins (in a 6:37:57 ratio)\u2014that contribute to its protective role against pathogens",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 ."
      ],
      "computed_relevance": 0.4444444444444444,
      "computed_utilization": 0.4444444444444444,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. However, the question is about single-wave pandemics, so this might not be directly relevant. But there's a mention of considering herald waves of the 1918 pandemic possibly stretching back to 1915. The 1918 pandemic is known for having multiple waves, though. So maybe not directly applicable here.\n\nNext, the second context about the 2009 pandemic in Hong Kong discusses convalescent plasma treatment and models. It mentions evidence from a small study, but it's about treatment, not the structure of the pandemic waves.\n\nThe third context, \"On Temporal Patterns...\" from Taiwan, talks about multi-wave epidemics using the Richards model. They mention distinguishing between two types of turning points in multi-wave scenarios. However, the question is about single-wave, so this might not fit unless there's a contrast. The study itself is about the 2009 pH1N1, which had multiple waves, so again, not directly about single-wave.\n\nThe fourth context is an economic analysis of mitigation strategies for five pandemic severities. It references studies using individual-based models. The passage doesn't specify if these are single-wave or multi-wave scenarios. The question is about research on severe, single-wave pandemics, so maybe this is related. The study considers different severities and interventions, but it's unclear if they focus on single-wave events.\n\nLooking back, the first context's mention of the 1889 pandemic had three waves, but the user is asking about single-wave. However, the 1918 pandemic is mentioned in the first context as having herald waves possibly starting in 1915, but the main 1918 pandemic had multiple waves. Wait, maybe the 1918 pandemic isn't a single wave. So perhaps there's no direct mention of single-wave pandemics in the contexts provided. But the user is asking about past research on such events.\n\nWait, the third context's passage says",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the context provided. The user is asking for the number of reported viral pneumonia cases, so I need to look through each of the provided passages to see if they mention any numbers related to viral pneumonia.\n\nFirst, looking at the first passage titled \"Clinical review: Primary influenza viral pneumonia,\" it mentions bacterial co-infection in the 2009 H1N1 pandemic. It says that 29% of 77 fatal cases had concurrent bacterial pneumonia. But this is about bacterial co-infection, not the number of viral pneumonia cases. So maybe not directly relevant here.\n\nNext, the second passage is about pneumonia in adults hospitalized with seasonal influenza in the US from 2005\u20132008. It states that patients with pneumonia were more likely to receive antiviral therapy. Again, this is about treatment differences, not the count of viral pneumonia cases.\n\nThe third passage is about the 2019-nCoV (now known as COVID-19) pneumonia cases. It says that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems like a direct mention of viral pneumonia cases caused by the novel coronavirus. The question is about \"reported viral pneumonia,\" so this might be the key number here.\n\nThe fourth passage again talks about influenza attack rates, giving percentages for different age groups during the 2009 H1N1 pandemic. It mentions clinical attack rates but not specific numbers of cases. So probably not the answer here.\n\nAdditionally, the last part of the context mentions \"A total of 51 cases have been cured and discharged. At present, 5794 suspected cases...\" but it doesn't specify which virus these cases are related to. However, given the previous mention of 2744 confirmed cases of 2019-nCoV pneumonia, it's possible that the 51 cured and 5794 suspected are part of that same context. However, the question is about \"reported viral pneumonia,\" and the only specific number given is 2744 confirmed cases from the third passage. The other numbers (51, 5794, etc.) are about suspected cases and those under observation, but the confirmed cases are",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.1111111111111111,
      "computed_completeness": 0.5,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look at the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination studies but doesn't talk about the primary method. The third passage discusses genome analyses and specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage talks about vigilance and data sharing but not the analysis method. \n\nSo the answer is definitely from the first passage. High throughput or deep sequencing is the main method used. The user might be looking for technical terms related to genetic analysis, so using the exact terms from the context is important. I should present the answer clearly, quoting the method as stated.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "The technique can produce genomic ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the methods mentioned.\n\nFirst, in the first passage about influenza A viruses, they mention using IVIS for whole-organ imaging of the lungs ex vivo. IVIS is an in vivo imaging system, so that's one method. They also used flow cytometry to analyze infection progression in antigen-presenting cells. Then, they did imaging of murine lungs to show the infection starts near large airways and spreads deeper. So that's IVIS, flow cytometry, and direct imaging of the lungs.\n\nIn the second passage about bat cell lines, they used an inverted fluorescence microscope to monitor GFP expression during passaging. Also, they generated single-cell clones with GFP and used limiting dilution. The images show GFP-expressing cells in white and others in black. So microscopy here is another method.\n\nPutting it all together, the tracking methods include IVIS for whole-organ imaging, flow cytometry for cell analysis, fluorescence microscopy for observing cells, and possibly imaging of lung sections. The answer should list these techniques as the ways they tracked the spread.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **in vivo imaging (IVIS) for whole-organ imaging of lungs ex vivo**, **flow cytometry** to analyze infection progression in antigen-presenting cells, and **fluorescence microscopy** (including inverted fluorescence microscopy and imaging of murine lungs) to observe GFP expression and spatial distribution in tissues and cells. These methods allowed visualization of infection dynamics, such as the initial localization near airways and subsequent spread to deeper lung regions.",
      "retrieved_chunks": [
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection after examination, and preparing to disinfect imaging equipment immediately after the exam.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe they mean that even if the CT is noncontaminated, they still follow procedures. But the main takeaway is that the equipment is disinfected right after the exam.\n\nSo the answer should state that the recommended procedure is to disinfect the CT scanner immediately after the examination using the specified sterilization procedures. The context doesn't go into specific steps like which disinfectants to use, but the answer should reflect the timing and the action taken.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that healthcare personnel should prepare and perform disinfection promptly after the procedure to mitigate contamination risks, particularly after examining suspected or confirmed COVID-19 cases. Specific steps likely include using appropriate disinfectants and following institutional guidelines for high-touch surfaces and equipment.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}